nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxepin—CYP2D6—Fingolimod—multiple sclerosis	0.0498	0.127	CbGbCtD
Doxepin—ABCB1—Methylprednisolone—multiple sclerosis	0.0341	0.0868	CbGbCtD
Doxepin—CYP3A4—Fingolimod—multiple sclerosis	0.0317	0.0807	CbGbCtD
Doxepin—CYP2C19—Prednisone—multiple sclerosis	0.0256	0.0652	CbGbCtD
Doxepin—ABCB1—Mitoxantrone—multiple sclerosis	0.0248	0.0633	CbGbCtD
Doxepin—ABCB1—Betamethasone—multiple sclerosis	0.0221	0.0564	CbGbCtD
Doxepin—ABCB1—Prednisolone—multiple sclerosis	0.0219	0.0557	CbGbCtD
Doxepin—ABCB1—Prednisone—multiple sclerosis	0.0206	0.0526	CbGbCtD
Doxepin—CYP3A4—Methylprednisolone—multiple sclerosis	0.0204	0.052	CbGbCtD
Doxepin—HTR2A—trigeminal nucleus—multiple sclerosis	0.0163	0.147	CbGeAlD
Doxepin—CYP2C19—Dexamethasone—multiple sclerosis	0.016	0.0407	CbGbCtD
Doxepin—CYP3A4—Triamcinolone—multiple sclerosis	0.0155	0.0394	CbGbCtD
Doxepin—CYP3A4—Mitoxantrone—multiple sclerosis	0.0149	0.0379	CbGbCtD
Doxepin—CYP2C9—Dexamethasone—multiple sclerosis	0.0133	0.0338	CbGbCtD
Doxepin—CYP3A4—Betamethasone—multiple sclerosis	0.0133	0.0338	CbGbCtD
Doxepin—CYP3A4—Prednisolone—multiple sclerosis	0.0131	0.0334	CbGbCtD
Doxepin—ABCB1—Dexamethasone—multiple sclerosis	0.0129	0.0328	CbGbCtD
Doxepin—CYP3A4—Prednisone—multiple sclerosis	0.0124	0.0315	CbGbCtD
Doxepin—CYP2D6—Dexamethasone—multiple sclerosis	0.0121	0.0309	CbGbCtD
Doxepin—ABCB1—Methotrexate—multiple sclerosis	0.0104	0.0264	CbGbCtD
Doxepin—CYP3A4—Dexamethasone—multiple sclerosis	0.00772	0.0197	CbGbCtD
Doxepin—HTR2A—trigeminal nerve—multiple sclerosis	0.00428	0.0385	CbGeAlD
Doxepin—HTR2A—pons—multiple sclerosis	0.00301	0.0271	CbGeAlD
Doxepin—SLC6A2—nerve—multiple sclerosis	0.0026	0.0234	CbGeAlD
Doxepin—DRD2—nerve—multiple sclerosis	0.00237	0.0213	CbGeAlD
Doxepin—ADRA2A—peripheral nervous system—multiple sclerosis	0.00236	0.0212	CbGeAlD
Doxepin—HTR2A—pineal body—multiple sclerosis	0.00215	0.0193	CbGeAlD
Doxepin—HTR2A—peripheral nervous system—multiple sclerosis	0.002	0.018	CbGeAlD
Doxepin—HTR2A—nerve—multiple sclerosis	0.00156	0.0141	CbGeAlD
Doxepin—CHRM4—nervous system—multiple sclerosis	0.00135	0.0122	CbGeAlD
Doxepin—HTR2C—brainstem—multiple sclerosis	0.00134	0.012	CbGeAlD
Doxepin—CHRM4—central nervous system—multiple sclerosis	0.0013	0.0117	CbGeAlD
Doxepin—SLC6A4—brainstem—multiple sclerosis	0.00127	0.0114	CbGeAlD
Doxepin—HTR6—nervous system—multiple sclerosis	0.00121	0.0109	CbGeAlD
Doxepin—HTR6—central nervous system—multiple sclerosis	0.00117	0.0105	CbGeAlD
Doxepin—HTR1A—brainstem—multiple sclerosis	0.00113	0.0101	CbGeAlD
Doxepin—SLC6A2—brainstem—multiple sclerosis	0.00112	0.01	CbGeAlD
Doxepin—HRH2—nervous system—multiple sclerosis	0.00111	0.00997	CbGeAlD
Doxepin—HRH2—central nervous system—multiple sclerosis	0.00107	0.0096	CbGeAlD
Doxepin—CHRM5—nervous system—multiple sclerosis	0.00106	0.00952	CbGeAlD
Doxepin—ADRA1A—brainstem—multiple sclerosis	0.00104	0.00933	CbGeAlD
Doxepin—CHRM4—brain—multiple sclerosis	0.00104	0.00931	CbGeAlD
Doxepin—CHRM5—central nervous system—multiple sclerosis	0.00102	0.00917	CbGeAlD
Doxepin—DRD2—brainstem—multiple sclerosis	0.00102	0.00915	CbGeAlD
Doxepin—DRD2—retina—multiple sclerosis	0.000981	0.00882	CbGeAlD
Doxepin—ADRA1B—nervous system—multiple sclerosis	0.000968	0.0087	CbGeAlD
Doxepin—ADRA1D—nervous system—multiple sclerosis	0.000946	0.00851	CbGeAlD
Doxepin—HTR2C—medulla oblongata—multiple sclerosis	0.000932	0.00839	CbGeAlD
Doxepin—ADRA1B—central nervous system—multiple sclerosis	0.000932	0.00838	CbGeAlD
Doxepin—HTR6—brain—multiple sclerosis	0.000927	0.00833	CbGeAlD
Doxepin—ORM1—spinal cord—multiple sclerosis	0.000925	0.00832	CbGeAlD
Doxepin—ADRA1D—central nervous system—multiple sclerosis	0.000911	0.0082	CbGeAlD
Doxepin—HTR2C—midbrain—multiple sclerosis	0.000852	0.00767	CbGeAlD
Doxepin—HRH2—brain—multiple sclerosis	0.000847	0.00762	CbGeAlD
Doxepin—HTR2C—spinal cord—multiple sclerosis	0.000831	0.00748	CbGeAlD
Doxepin—CHRM5—brain—multiple sclerosis	0.000809	0.00728	CbGeAlD
Doxepin—SLC6A4—midbrain—multiple sclerosis	0.000808	0.00727	CbGeAlD
Doxepin—SLC6A4—spinal cord—multiple sclerosis	0.000788	0.00709	CbGeAlD
Doxepin—ORM1—nervous system—multiple sclerosis	0.000779	0.00701	CbGeAlD
Doxepin—SLC6A2—medulla oblongata—multiple sclerosis	0.000778	0.007	CbGeAlD
Doxepin—ORM1—central nervous system—multiple sclerosis	0.00075	0.00675	CbGeAlD
Doxepin—ADRA1B—brain—multiple sclerosis	0.00074	0.00665	CbGeAlD
Doxepin—CHRM2—nervous system—multiple sclerosis	0.000727	0.00654	CbGeAlD
Doxepin—ADRA1D—brain—multiple sclerosis	0.000723	0.00651	CbGeAlD
Doxepin—HTR1A—midbrain—multiple sclerosis	0.000717	0.00645	CbGeAlD
Doxepin—HTR2C—nervous system—multiple sclerosis	0.000701	0.0063	CbGeAlD
Doxepin—HTR1A—spinal cord—multiple sclerosis	0.0007	0.00629	CbGeAlD
Doxepin—CHRM2—central nervous system—multiple sclerosis	0.0007	0.00629	CbGeAlD
Doxepin—KCNH2—medulla oblongata—multiple sclerosis	0.000699	0.00628	CbGeAlD
Doxepin—ADRA2C—medulla oblongata—multiple sclerosis	0.000689	0.0062	CbGeAlD
Doxepin—HTR2C—central nervous system—multiple sclerosis	0.000675	0.00607	CbGeAlD
Doxepin—HTR2A—brainstem—multiple sclerosis	0.000671	0.00603	CbGeAlD
Doxepin—SLC6A4—nervous system—multiple sclerosis	0.000664	0.00597	CbGeAlD
Doxepin—CHRM1—nervous system—multiple sclerosis	0.000662	0.00595	CbGeAlD
Doxepin—HTR2B—nervous system—multiple sclerosis	0.000658	0.00592	CbGeAlD
Doxepin—DRD2—midbrain—multiple sclerosis	0.000648	0.00583	CbGeAlD
Doxepin—HTR2A—retina—multiple sclerosis	0.000647	0.00582	CbGeAlD
Doxepin—SLC6A4—central nervous system—multiple sclerosis	0.000639	0.00575	CbGeAlD
Doxepin—KCNH2—midbrain—multiple sclerosis	0.000639	0.00574	CbGeAlD
Doxepin—CHRM1—central nervous system—multiple sclerosis	0.000637	0.00573	CbGeAlD
Doxepin—HTR2B—central nervous system—multiple sclerosis	0.000634	0.0057	CbGeAlD
Doxepin—ADRA2C—midbrain—multiple sclerosis	0.00063	0.00567	CbGeAlD
Doxepin—KCNH2—spinal cord—multiple sclerosis	0.000623	0.0056	CbGeAlD
Doxepin—ADRA2C—spinal cord—multiple sclerosis	0.000615	0.00553	CbGeAlD
Doxepin—CYP2D6—brainstem—multiple sclerosis	0.000611	0.0055	CbGeAlD
Doxepin—CHRM3—nervous system—multiple sclerosis	0.000592	0.00533	CbGeAlD
Doxepin—HTR1A—nervous system—multiple sclerosis	0.00059	0.0053	CbGeAlD
Doxepin—SLC6A2—nervous system—multiple sclerosis	0.000585	0.00526	CbGeAlD
Doxepin—CHRM3—central nervous system—multiple sclerosis	0.00057	0.00513	CbGeAlD
Doxepin—HTR1A—central nervous system—multiple sclerosis	0.000568	0.00511	CbGeAlD
Doxepin—SLC6A2—central nervous system—multiple sclerosis	0.000563	0.00506	CbGeAlD
Doxepin—CHRM2—brain—multiple sclerosis	0.000556	0.005	CbGeAlD
Doxepin—HTR1A—cerebellum—multiple sclerosis	0.000555	0.00499	CbGeAlD
Doxepin—ADRA2A—medulla oblongata—multiple sclerosis	0.00055	0.00495	CbGeAlD
Doxepin—ADRA1A—nervous system—multiple sclerosis	0.000544	0.00489	CbGeAlD
Doxepin—HTR2C—brain—multiple sclerosis	0.000536	0.00482	CbGeAlD
Doxepin—DRD2—nervous system—multiple sclerosis	0.000533	0.00479	CbGeAlD
Doxepin—KCNH2—nervous system—multiple sclerosis	0.000525	0.00472	CbGeAlD
Doxepin—ADRA1A—central nervous system—multiple sclerosis	0.000523	0.00471	CbGeAlD
Doxepin—ADRA2C—nervous system—multiple sclerosis	0.000518	0.00466	CbGeAlD
Doxepin—DRD2—central nervous system—multiple sclerosis	0.000513	0.00461	CbGeAlD
Doxepin—ADRA1A—cerebellum—multiple sclerosis	0.000512	0.0046	CbGeAlD
Doxepin—SLC6A4—brain—multiple sclerosis	0.000508	0.00457	CbGeAlD
Doxepin—CHRM1—brain—multiple sclerosis	0.000506	0.00455	CbGeAlD
Doxepin—KCNH2—central nervous system—multiple sclerosis	0.000505	0.00455	CbGeAlD
Doxepin—HTR2B—brain—multiple sclerosis	0.000503	0.00452	CbGeAlD
Doxepin—ADRA2A—midbrain—multiple sclerosis	0.000503	0.00452	CbGeAlD
Doxepin—DRD2—cerebellum—multiple sclerosis	0.000501	0.00451	CbGeAlD
Doxepin—ADRA2C—central nervous system—multiple sclerosis	0.000499	0.00449	CbGeAlD
Doxepin—KCNH2—cerebellum—multiple sclerosis	0.000494	0.00444	CbGeAlD
Doxepin—ADRA2A—spinal cord—multiple sclerosis	0.000491	0.00441	CbGeAlD
Doxepin—ADRA2C—cerebellum—multiple sclerosis	0.000487	0.00438	CbGeAlD
Doxepin—HTR2A—medulla oblongata—multiple sclerosis	0.000468	0.00421	CbGeAlD
Doxepin—CHRM3—brain—multiple sclerosis	0.000453	0.00407	CbGeAlD
Doxepin—HTR1A—brain—multiple sclerosis	0.000451	0.00405	CbGeAlD
Doxepin—SLC6A2—brain—multiple sclerosis	0.000447	0.00402	CbGeAlD
Doxepin—HTR2A—midbrain—multiple sclerosis	0.000428	0.00385	CbGeAlD
Doxepin—ABCB1—retina—multiple sclerosis	0.000424	0.00381	CbGeAlD
Doxepin—HRH1—nervous system—multiple sclerosis	0.000421	0.00378	CbGeAlD
Doxepin—HTR2A—spinal cord—multiple sclerosis	0.000417	0.00375	CbGeAlD
Doxepin—ADRA1A—brain—multiple sclerosis	0.000416	0.00374	CbGeAlD
Doxepin—ADRA2A—nervous system—multiple sclerosis	0.000413	0.00372	CbGeAlD
Doxepin—DRD2—brain—multiple sclerosis	0.000407	0.00366	CbGeAlD
Doxepin—HRH1—central nervous system—multiple sclerosis	0.000405	0.00364	CbGeAlD
Doxepin—KCNH2—brain—multiple sclerosis	0.000401	0.00361	CbGeAlD
Doxepin—ADRA2A—central nervous system—multiple sclerosis	0.000398	0.00358	CbGeAlD
Doxepin—ADRA2C—brain—multiple sclerosis	0.000396	0.00356	CbGeAlD
Doxepin—ADRA2A—cerebellum—multiple sclerosis	0.000389	0.0035	CbGeAlD
Doxepin—HTR2A—nervous system—multiple sclerosis	0.000351	0.00316	CbGeAlD
Doxepin—HTR2A—central nervous system—multiple sclerosis	0.000338	0.00304	CbGeAlD
Doxepin—HTR2A—cerebellum—multiple sclerosis	0.000331	0.00297	CbGeAlD
Doxepin—CYP3A4—nervous system—multiple sclerosis	0.000325	0.00293	CbGeAlD
Doxepin—HRH1—brain—multiple sclerosis	0.000322	0.00289	CbGeAlD
Doxepin—CYP2D6—nervous system—multiple sclerosis	0.00032	0.00288	CbGeAlD
Doxepin—ADRA2A—brain—multiple sclerosis	0.000316	0.00284	CbGeAlD
Doxepin—CYP3A4—central nervous system—multiple sclerosis	0.000313	0.00282	CbGeAlD
Doxepin—CYP2D6—central nervous system—multiple sclerosis	0.000308	0.00277	CbGeAlD
Doxepin—ABCB1—medulla oblongata—multiple sclerosis	0.000307	0.00276	CbGeAlD
Doxepin—CYP2D6—cerebellum—multiple sclerosis	0.000301	0.00271	CbGeAlD
Doxepin—ABCB1—midbrain—multiple sclerosis	0.00028	0.00252	CbGeAlD
Doxepin—ABCB1—spinal cord—multiple sclerosis	0.000273	0.00246	CbGeAlD
Doxepin—HTR2A—brain—multiple sclerosis	0.000269	0.00242	CbGeAlD
Doxepin—CYP2D6—brain—multiple sclerosis	0.000245	0.0022	CbGeAlD
Doxepin—ABCB1—nervous system—multiple sclerosis	0.00023	0.00207	CbGeAlD
Doxepin—ABCB1—central nervous system—multiple sclerosis	0.000222	0.00199	CbGeAlD
Doxepin—ABCB1—cerebellum—multiple sclerosis	0.000217	0.00195	CbGeAlD
Doxepin—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000202	0.000646	CcSEcCtD
Doxepin—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000202	0.000645	CcSEcCtD
Doxepin—Loss of consciousness—Betamethasone—multiple sclerosis	0.000202	0.000645	CcSEcCtD
Doxepin—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000202	0.000644	CcSEcCtD
Doxepin—Paraesthesia—Prednisolone—multiple sclerosis	0.000202	0.000644	CcSEcCtD
Doxepin—Tachycardia—Triamcinolone—multiple sclerosis	0.000202	0.000644	CcSEcCtD
Doxepin—Mental disorder—Prednisone—multiple sclerosis	0.000201	0.000643	CcSEcCtD
Doxepin—Nausea—Azathioprine—multiple sclerosis	0.000201	0.000643	CcSEcCtD
Doxepin—Tachycardia—Methylprednisolone—multiple sclerosis	0.000201	0.000643	CcSEcCtD
Doxepin—Skin disorder—Methylprednisolone—multiple sclerosis	0.0002	0.000639	CcSEcCtD
Doxepin—Erythema—Prednisone—multiple sclerosis	0.0002	0.000639	CcSEcCtD
Doxepin—Malnutrition—Prednisone—multiple sclerosis	0.0002	0.000639	CcSEcCtD
Doxepin—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.0002	0.000638	CcSEcCtD
Doxepin—Agranulocytosis—Methotrexate—multiple sclerosis	0.0002	0.000638	CcSEcCtD
Doxepin—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000199	0.000636	CcSEcCtD
Doxepin—Convulsion—Betamethasone—multiple sclerosis	0.000199	0.000636	CcSEcCtD
Doxepin—Convulsion—Dexamethasone—multiple sclerosis	0.000199	0.000636	CcSEcCtD
Doxepin—Hypertension—Betamethasone—multiple sclerosis	0.000198	0.000633	CcSEcCtD
Doxepin—Hypertension—Dexamethasone—multiple sclerosis	0.000198	0.000633	CcSEcCtD
Doxepin—Asthenia—Mitoxantrone—multiple sclerosis	0.000197	0.000627	CcSEcCtD
Doxepin—Myalgia—Dexamethasone—multiple sclerosis	0.000196	0.000625	CcSEcCtD
Doxepin—Myalgia—Betamethasone—multiple sclerosis	0.000196	0.000625	CcSEcCtD
Doxepin—Anxiety—Dexamethasone—multiple sclerosis	0.000195	0.000622	CcSEcCtD
Doxepin—Anxiety—Betamethasone—multiple sclerosis	0.000195	0.000622	CcSEcCtD
Doxepin—Discomfort—Dexamethasone—multiple sclerosis	0.000193	0.000617	CcSEcCtD
Doxepin—Discomfort—Betamethasone—multiple sclerosis	0.000193	0.000617	CcSEcCtD
Doxepin—Hypotension—Methylprednisolone—multiple sclerosis	0.000193	0.000615	CcSEcCtD
Doxepin—Pain—Prednisolone—multiple sclerosis	0.000192	0.000614	CcSEcCtD
Doxepin—Hepatitis—Methotrexate—multiple sclerosis	0.000192	0.000613	CcSEcCtD
Doxepin—Pharyngitis—Methotrexate—multiple sclerosis	0.000191	0.000609	CcSEcCtD
Doxepin—Urinary tract disorder—Methotrexate—multiple sclerosis	0.00019	0.000606	CcSEcCtD
Doxepin—Vision blurred—Prednisone—multiple sclerosis	0.000189	0.000602	CcSEcCtD
Doxepin—Urethral disorder—Methotrexate—multiple sclerosis	0.000188	0.000601	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000188	0.000601	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000188	0.0006	CcSEcCtD
Doxepin—Oedema—Dexamethasone—multiple sclerosis	0.000188	0.000599	CcSEcCtD
Doxepin—Oedema—Betamethasone—multiple sclerosis	0.000188	0.000599	CcSEcCtD
Doxepin—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000187	0.000598	CcSEcCtD
Doxepin—Insomnia—Triamcinolone—multiple sclerosis	0.000187	0.000597	CcSEcCtD
Doxepin—Insomnia—Methylprednisolone—multiple sclerosis	0.000187	0.000595	CcSEcCtD
Doxepin—Infection—Betamethasone—multiple sclerosis	0.000186	0.000595	CcSEcCtD
Doxepin—Infection—Dexamethasone—multiple sclerosis	0.000186	0.000595	CcSEcCtD
Doxepin—Ill-defined disorder—Prednisone—multiple sclerosis	0.000186	0.000593	CcSEcCtD
Doxepin—Paraesthesia—Triamcinolone—multiple sclerosis	0.000186	0.000592	CcSEcCtD
Doxepin—Feeling abnormal—Prednisolone—multiple sclerosis	0.000185	0.000591	CcSEcCtD
Doxepin—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000185	0.000591	CcSEcCtD
Doxepin—Anaemia—Prednisone—multiple sclerosis	0.000185	0.00059	CcSEcCtD
Doxepin—Shock—Dexamethasone—multiple sclerosis	0.000185	0.000589	CcSEcCtD
Doxepin—Shock—Betamethasone—multiple sclerosis	0.000185	0.000589	CcSEcCtD
Doxepin—Dyspnoea—Triamcinolone—multiple sclerosis	0.000184	0.000588	CcSEcCtD
Doxepin—Nervous system disorder—Betamethasone—multiple sclerosis	0.000184	0.000587	CcSEcCtD
Doxepin—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000184	0.000587	CcSEcCtD
Doxepin—Agitation—Prednisone—multiple sclerosis	0.000184	0.000587	CcSEcCtD
Doxepin—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000184	0.000586	CcSEcCtD
Doxepin—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000184	0.000586	CcSEcCtD
Doxepin—Tachycardia—Dexamethasone—multiple sclerosis	0.000183	0.000584	CcSEcCtD
Doxepin—Tachycardia—Betamethasone—multiple sclerosis	0.000183	0.000584	CcSEcCtD
Doxepin—Dyspepsia—Triamcinolone—multiple sclerosis	0.000182	0.000581	CcSEcCtD
Doxepin—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000182	0.00058	CcSEcCtD
Doxepin—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000181	0.000579	CcSEcCtD
Doxepin—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000181	0.000579	CcSEcCtD
Doxepin—Malaise—Prednisone—multiple sclerosis	0.00018	0.000576	CcSEcCtD
Doxepin—Vertigo—Prednisone—multiple sclerosis	0.00018	0.000574	CcSEcCtD
Doxepin—Eye disorder—Methotrexate—multiple sclerosis	0.00018	0.000573	CcSEcCtD
Doxepin—Syncope—Prednisone—multiple sclerosis	0.000179	0.000573	CcSEcCtD
Doxepin—Tinnitus—Methotrexate—multiple sclerosis	0.000179	0.000572	CcSEcCtD
Doxepin—Anorexia—Betamethasone—multiple sclerosis	0.000179	0.000571	CcSEcCtD
Doxepin—Anorexia—Dexamethasone—multiple sclerosis	0.000179	0.000571	CcSEcCtD
Doxepin—Urticaria—Prednisolone—multiple sclerosis	0.000179	0.00057	CcSEcCtD
Doxepin—Cardiac disorder—Methotrexate—multiple sclerosis	0.000178	0.000569	CcSEcCtD
Doxepin—Fatigue—Triamcinolone—multiple sclerosis	0.000178	0.000569	CcSEcCtD
Doxepin—Fatigue—Methylprednisolone—multiple sclerosis	0.000178	0.000568	CcSEcCtD
Doxepin—Pain—Triamcinolone—multiple sclerosis	0.000177	0.000564	CcSEcCtD
Doxepin—ABCB1—brain—multiple sclerosis	0.000176	0.00158	CbGeAlD
Doxepin—Loss of consciousness—Prednisone—multiple sclerosis	0.000176	0.000561	CcSEcCtD
Doxepin—Hypotension—Dexamethasone—multiple sclerosis	0.000175	0.000559	CcSEcCtD
Doxepin—Hypotension—Betamethasone—multiple sclerosis	0.000175	0.000559	CcSEcCtD
Doxepin—Angiopathy—Methotrexate—multiple sclerosis	0.000174	0.000556	CcSEcCtD
Doxepin—Vomiting—Mitoxantrone—multiple sclerosis	0.000174	0.000556	CcSEcCtD
Doxepin—Immune system disorder—Methotrexate—multiple sclerosis	0.000174	0.000554	CcSEcCtD
Doxepin—Convulsion—Prednisone—multiple sclerosis	0.000173	0.000554	CcSEcCtD
Doxepin—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000173	0.000553	CcSEcCtD
Doxepin—Hypertension—Prednisone—multiple sclerosis	0.000173	0.000552	CcSEcCtD
Doxepin—Rash—Mitoxantrone—multiple sclerosis	0.000173	0.000551	CcSEcCtD
Doxepin—Dermatitis—Mitoxantrone—multiple sclerosis	0.000173	0.000551	CcSEcCtD
Doxepin—Chills—Methotrexate—multiple sclerosis	0.000172	0.00055	CcSEcCtD
Doxepin—Headache—Mitoxantrone—multiple sclerosis	0.000172	0.000548	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000171	0.000545	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000171	0.000545	CcSEcCtD
Doxepin—Myalgia—Prednisone—multiple sclerosis	0.00017	0.000544	CcSEcCtD
Doxepin—Arthralgia—Prednisone—multiple sclerosis	0.00017	0.000544	CcSEcCtD
Doxepin—Feeling abnormal—Triamcinolone—multiple sclerosis	0.00017	0.000544	CcSEcCtD
Doxepin—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.00017	0.000543	CcSEcCtD
Doxepin—Anxiety—Prednisone—multiple sclerosis	0.00017	0.000542	CcSEcCtD
Doxepin—Alopecia—Methotrexate—multiple sclerosis	0.00017	0.000542	CcSEcCtD
Doxepin—Insomnia—Betamethasone—multiple sclerosis	0.00017	0.000541	CcSEcCtD
Doxepin—Insomnia—Dexamethasone—multiple sclerosis	0.00017	0.000541	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000169	0.00054	CcSEcCtD
Doxepin—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000169	0.000538	CcSEcCtD
Doxepin—Paraesthesia—Betamethasone—multiple sclerosis	0.000168	0.000538	CcSEcCtD
Doxepin—Paraesthesia—Dexamethasone—multiple sclerosis	0.000168	0.000538	CcSEcCtD
Doxepin—Discomfort—Prednisone—multiple sclerosis	0.000168	0.000537	CcSEcCtD
Doxepin—Mental disorder—Methotrexate—multiple sclerosis	0.000168	0.000537	CcSEcCtD
Doxepin—Erythema—Methotrexate—multiple sclerosis	0.000167	0.000534	CcSEcCtD
Doxepin—Malnutrition—Methotrexate—multiple sclerosis	0.000167	0.000534	CcSEcCtD
Doxepin—Hypersensitivity—Prednisolone—multiple sclerosis	0.000166	0.000529	CcSEcCtD
Doxepin—Dyspepsia—Dexamethasone—multiple sclerosis	0.000165	0.000527	CcSEcCtD
Doxepin—Dyspepsia—Betamethasone—multiple sclerosis	0.000165	0.000527	CcSEcCtD
Doxepin—Urticaria—Triamcinolone—multiple sclerosis	0.000164	0.000524	CcSEcCtD
Doxepin—Urticaria—Methylprednisolone—multiple sclerosis	0.000164	0.000523	CcSEcCtD
Doxepin—Dysgeusia—Methotrexate—multiple sclerosis	0.000164	0.000523	CcSEcCtD
Doxepin—Body temperature increased—Triamcinolone—multiple sclerosis	0.000163	0.000522	CcSEcCtD
Doxepin—Oedema—Prednisone—multiple sclerosis	0.000163	0.000521	CcSEcCtD
Doxepin—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000163	0.00052	CcSEcCtD
Doxepin—Decreased appetite—Dexamethasone—multiple sclerosis	0.000163	0.00052	CcSEcCtD
Doxepin—Decreased appetite—Betamethasone—multiple sclerosis	0.000163	0.00052	CcSEcCtD
Doxepin—Nausea—Mitoxantrone—multiple sclerosis	0.000163	0.000519	CcSEcCtD
Doxepin—Infection—Prednisone—multiple sclerosis	0.000162	0.000518	CcSEcCtD
Doxepin—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000162	0.000517	CcSEcCtD
Doxepin—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000162	0.000517	CcSEcCtD
Doxepin—Back pain—Methotrexate—multiple sclerosis	0.000162	0.000516	CcSEcCtD
Doxepin—Fatigue—Dexamethasone—multiple sclerosis	0.000162	0.000516	CcSEcCtD
Doxepin—Fatigue—Betamethasone—multiple sclerosis	0.000162	0.000516	CcSEcCtD
Doxepin—Shock—Prednisone—multiple sclerosis	0.000161	0.000513	CcSEcCtD
Doxepin—Pain—Betamethasone—multiple sclerosis	0.00016	0.000512	CcSEcCtD
Doxepin—Pain—Dexamethasone—multiple sclerosis	0.00016	0.000512	CcSEcCtD
Doxepin—Nervous system disorder—Prednisone—multiple sclerosis	0.00016	0.000511	CcSEcCtD
Doxepin—Tachycardia—Prednisone—multiple sclerosis	0.000159	0.000509	CcSEcCtD
Doxepin—Skin disorder—Prednisone—multiple sclerosis	0.000159	0.000506	CcSEcCtD
Doxepin—Hyperhidrosis—Prednisone—multiple sclerosis	0.000158	0.000504	CcSEcCtD
Doxepin—Vision blurred—Methotrexate—multiple sclerosis	0.000158	0.000503	CcSEcCtD
Doxepin—Anorexia—Prednisone—multiple sclerosis	0.000156	0.000497	CcSEcCtD
Doxepin—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000155	0.000495	CcSEcCtD
Doxepin—Anaemia—Methotrexate—multiple sclerosis	0.000155	0.000493	CcSEcCtD
Doxepin—Feeling abnormal—Betamethasone—multiple sclerosis	0.000155	0.000493	CcSEcCtD
Doxepin—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000155	0.000493	CcSEcCtD
Doxepin—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000153	0.00049	CcSEcCtD
Doxepin—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000153	0.00049	CcSEcCtD
Doxepin—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000152	0.000486	CcSEcCtD
Doxepin—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000152	0.000485	CcSEcCtD
Doxepin—Malaise—Methotrexate—multiple sclerosis	0.000151	0.000481	CcSEcCtD
Doxepin—Vertigo—Methotrexate—multiple sclerosis	0.00015	0.00048	CcSEcCtD
Doxepin—Leukopenia—Methotrexate—multiple sclerosis	0.00015	0.000478	CcSEcCtD
Doxepin—Urticaria—Dexamethasone—multiple sclerosis	0.000149	0.000476	CcSEcCtD
Doxepin—Urticaria—Betamethasone—multiple sclerosis	0.000149	0.000476	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000149	0.000475	CcSEcCtD
Doxepin—Dizziness—Prednisolone—multiple sclerosis	0.000149	0.000474	CcSEcCtD
Doxepin—Asthenia—Triamcinolone—multiple sclerosis	0.000148	0.000473	CcSEcCtD
Doxepin—Abdominal pain—Dexamethasone—multiple sclerosis	0.000148	0.000473	CcSEcCtD
Doxepin—Body temperature increased—Betamethasone—multiple sclerosis	0.000148	0.000473	CcSEcCtD
Doxepin—Body temperature increased—Dexamethasone—multiple sclerosis	0.000148	0.000473	CcSEcCtD
Doxepin—Abdominal pain—Betamethasone—multiple sclerosis	0.000148	0.000473	CcSEcCtD
Doxepin—Asthenia—Methylprednisolone—multiple sclerosis	0.000148	0.000472	CcSEcCtD
Doxepin—Insomnia—Prednisone—multiple sclerosis	0.000148	0.000472	CcSEcCtD
Doxepin—Paraesthesia—Prednisone—multiple sclerosis	0.000147	0.000468	CcSEcCtD
Doxepin—Pruritus—Triamcinolone—multiple sclerosis	0.000146	0.000467	CcSEcCtD
Doxepin—Cough—Methotrexate—multiple sclerosis	0.000146	0.000466	CcSEcCtD
Doxepin—Pruritus—Methylprednisolone—multiple sclerosis	0.000146	0.000466	CcSEcCtD
Doxepin—Convulsion—Methotrexate—multiple sclerosis	0.000145	0.000463	CcSEcCtD
Doxepin—Dyspepsia—Prednisone—multiple sclerosis	0.000144	0.000459	CcSEcCtD
Doxepin—Arthralgia—Methotrexate—multiple sclerosis	0.000142	0.000455	CcSEcCtD
Doxepin—Myalgia—Methotrexate—multiple sclerosis	0.000142	0.000455	CcSEcCtD
Doxepin—Chest pain—Methotrexate—multiple sclerosis	0.000142	0.000455	CcSEcCtD
Doxepin—Decreased appetite—Prednisone—multiple sclerosis	0.000142	0.000453	CcSEcCtD
Doxepin—Rash—Prednisolone—multiple sclerosis	0.000142	0.000452	CcSEcCtD
Doxepin—Dermatitis—Prednisolone—multiple sclerosis	0.000142	0.000452	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000141	0.000451	CcSEcCtD
Doxepin—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000141	0.00045	CcSEcCtD
Doxepin—Fatigue—Prednisone—multiple sclerosis	0.000141	0.00045	CcSEcCtD
Doxepin—Headache—Prednisolone—multiple sclerosis	0.000141	0.000449	CcSEcCtD
Doxepin—Discomfort—Methotrexate—multiple sclerosis	0.000141	0.000449	CcSEcCtD
Doxepin—Constipation—Prednisone—multiple sclerosis	0.00014	0.000446	CcSEcCtD
Doxepin—Confusional state—Methotrexate—multiple sclerosis	0.000138	0.000439	CcSEcCtD
Doxepin—Dizziness—Triamcinolone—multiple sclerosis	0.000137	0.000436	CcSEcCtD
Doxepin—Dizziness—Methylprednisolone—multiple sclerosis	0.000136	0.000435	CcSEcCtD
Doxepin—Infection—Methotrexate—multiple sclerosis	0.000136	0.000433	CcSEcCtD
Doxepin—Feeling abnormal—Prednisone—multiple sclerosis	0.000135	0.00043	CcSEcCtD
Doxepin—Asthenia—Dexamethasone—multiple sclerosis	0.000135	0.00043	CcSEcCtD
Doxepin—Asthenia—Betamethasone—multiple sclerosis	0.000135	0.00043	CcSEcCtD
Doxepin—Nervous system disorder—Methotrexate—multiple sclerosis	0.000134	0.000427	CcSEcCtD
Doxepin—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000134	0.000427	CcSEcCtD
Doxepin—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000134	0.000426	CcSEcCtD
Doxepin—Nausea—Prednisolone—multiple sclerosis	0.000134	0.000426	CcSEcCtD
Doxepin—Pruritus—Dexamethasone—multiple sclerosis	0.000133	0.000424	CcSEcCtD
Doxepin—Pruritus—Betamethasone—multiple sclerosis	0.000133	0.000424	CcSEcCtD
Doxepin—Skin disorder—Methotrexate—multiple sclerosis	0.000133	0.000423	CcSEcCtD
Doxepin—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000132	0.000421	CcSEcCtD
Doxepin—Vomiting—Triamcinolone—multiple sclerosis	0.000131	0.00042	CcSEcCtD
Doxepin—Vomiting—Methylprednisolone—multiple sclerosis	0.000131	0.000419	CcSEcCtD
Doxepin—Rash—Triamcinolone—multiple sclerosis	0.00013	0.000416	CcSEcCtD
Doxepin—Dermatitis—Triamcinolone—multiple sclerosis	0.00013	0.000416	CcSEcCtD
Doxepin—Anorexia—Methotrexate—multiple sclerosis	0.00013	0.000415	CcSEcCtD
Doxepin—Rash—Methylprednisolone—multiple sclerosis	0.00013	0.000415	CcSEcCtD
Doxepin—Dermatitis—Methylprednisolone—multiple sclerosis	0.00013	0.000415	CcSEcCtD
Doxepin—Urticaria—Prednisone—multiple sclerosis	0.00013	0.000414	CcSEcCtD
Doxepin—Headache—Triamcinolone—multiple sclerosis	0.00013	0.000413	CcSEcCtD
Doxepin—Headache—Methylprednisolone—multiple sclerosis	0.000129	0.000412	CcSEcCtD
Doxepin—Abdominal pain—Prednisone—multiple sclerosis	0.000129	0.000412	CcSEcCtD
Doxepin—Body temperature increased—Prednisone—multiple sclerosis	0.000129	0.000412	CcSEcCtD
Doxepin—Diarrhoea—Dexamethasone—multiple sclerosis	0.000128	0.00041	CcSEcCtD
Doxepin—Diarrhoea—Betamethasone—multiple sclerosis	0.000128	0.00041	CcSEcCtD
Doxepin—Hypotension—Methotrexate—multiple sclerosis	0.000128	0.000407	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000124	0.000397	CcSEcCtD
Doxepin—Dizziness—Betamethasone—multiple sclerosis	0.000124	0.000396	CcSEcCtD
Doxepin—Dizziness—Dexamethasone—multiple sclerosis	0.000124	0.000396	CcSEcCtD
Doxepin—Insomnia—Methotrexate—multiple sclerosis	0.000123	0.000394	CcSEcCtD
Doxepin—Nausea—Triamcinolone—multiple sclerosis	0.000123	0.000392	CcSEcCtD
Doxepin—Paraesthesia—Methotrexate—multiple sclerosis	0.000123	0.000391	CcSEcCtD
Doxepin—Nausea—Methylprednisolone—multiple sclerosis	0.000123	0.000391	CcSEcCtD
Doxepin—Dyspnoea—Methotrexate—multiple sclerosis	0.000122	0.000388	CcSEcCtD
Doxepin—Somnolence—Methotrexate—multiple sclerosis	0.000121	0.000387	CcSEcCtD
Doxepin—Hypersensitivity—Prednisone—multiple sclerosis	0.00012	0.000384	CcSEcCtD
Doxepin—Dyspepsia—Methotrexate—multiple sclerosis	0.00012	0.000384	CcSEcCtD
Doxepin—Vomiting—Betamethasone—multiple sclerosis	0.000119	0.000381	CcSEcCtD
Doxepin—Vomiting—Dexamethasone—multiple sclerosis	0.000119	0.000381	CcSEcCtD
Doxepin—Decreased appetite—Methotrexate—multiple sclerosis	0.000119	0.000379	CcSEcCtD
Doxepin—Rash—Betamethasone—multiple sclerosis	0.000118	0.000377	CcSEcCtD
Doxepin—Rash—Dexamethasone—multiple sclerosis	0.000118	0.000377	CcSEcCtD
Doxepin—Dermatitis—Betamethasone—multiple sclerosis	0.000118	0.000377	CcSEcCtD
Doxepin—Dermatitis—Dexamethasone—multiple sclerosis	0.000118	0.000377	CcSEcCtD
Doxepin—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000118	0.000376	CcSEcCtD
Doxepin—Fatigue—Methotrexate—multiple sclerosis	0.000118	0.000376	CcSEcCtD
Doxepin—Headache—Betamethasone—multiple sclerosis	0.000118	0.000375	CcSEcCtD
Doxepin—Headache—Dexamethasone—multiple sclerosis	0.000118	0.000375	CcSEcCtD
Doxepin—Asthenia—Prednisone—multiple sclerosis	0.000117	0.000374	CcSEcCtD
Doxepin—Pain—Methotrexate—multiple sclerosis	0.000117	0.000373	CcSEcCtD
Doxepin—Pruritus—Prednisone—multiple sclerosis	0.000116	0.000369	CcSEcCtD
Doxepin—Feeling abnormal—Methotrexate—multiple sclerosis	0.000112	0.000359	CcSEcCtD
Doxepin—Diarrhoea—Prednisone—multiple sclerosis	0.000112	0.000357	CcSEcCtD
Doxepin—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000112	0.000356	CcSEcCtD
Doxepin—Nausea—Dexamethasone—multiple sclerosis	0.000111	0.000356	CcSEcCtD
Doxepin—Nausea—Betamethasone—multiple sclerosis	0.000111	0.000356	CcSEcCtD
Doxepin—Urticaria—Methotrexate—multiple sclerosis	0.000108	0.000346	CcSEcCtD
Doxepin—Dizziness—Prednisone—multiple sclerosis	0.000108	0.000345	CcSEcCtD
Doxepin—Body temperature increased—Methotrexate—multiple sclerosis	0.000108	0.000344	CcSEcCtD
Doxepin—Abdominal pain—Methotrexate—multiple sclerosis	0.000108	0.000344	CcSEcCtD
Doxepin—Vomiting—Prednisone—multiple sclerosis	0.000104	0.000332	CcSEcCtD
Doxepin—Rash—Prednisone—multiple sclerosis	0.000103	0.000329	CcSEcCtD
Doxepin—Dermatitis—Prednisone—multiple sclerosis	0.000103	0.000328	CcSEcCtD
Doxepin—Headache—Prednisone—multiple sclerosis	0.000102	0.000327	CcSEcCtD
Doxepin—Hypersensitivity—Methotrexate—multiple sclerosis	0.000101	0.000321	CcSEcCtD
Doxepin—Asthenia—Methotrexate—multiple sclerosis	9.79e-05	0.000313	CcSEcCtD
Doxepin—Nausea—Prednisone—multiple sclerosis	9.7e-05	0.00031	CcSEcCtD
Doxepin—Pruritus—Methotrexate—multiple sclerosis	9.66e-05	0.000308	CcSEcCtD
Doxepin—Diarrhoea—Methotrexate—multiple sclerosis	9.34e-05	0.000298	CcSEcCtD
Doxepin—Dizziness—Methotrexate—multiple sclerosis	9.03e-05	0.000288	CcSEcCtD
Doxepin—Vomiting—Methotrexate—multiple sclerosis	8.68e-05	0.000277	CcSEcCtD
Doxepin—Rash—Methotrexate—multiple sclerosis	8.61e-05	0.000275	CcSEcCtD
Doxepin—Dermatitis—Methotrexate—multiple sclerosis	8.6e-05	0.000274	CcSEcCtD
Doxepin—Headache—Methotrexate—multiple sclerosis	8.55e-05	0.000273	CcSEcCtD
Doxepin—Nausea—Methotrexate—multiple sclerosis	8.11e-05	0.000259	CcSEcCtD
Doxepin—HTR1A—Signaling Pathways—CD80—multiple sclerosis	1.03e-05	5.63e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—CD80—multiple sclerosis	1.03e-05	5.61e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—POMC—multiple sclerosis	1.02e-05	5.55e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—SPP1—multiple sclerosis	1.01e-05	5.53e-05	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—POMC—multiple sclerosis	1e-05	5.48e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—APOE—multiple sclerosis	1e-05	5.47e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—TYK2—multiple sclerosis	9.99e-06	5.46e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—CD80—multiple sclerosis	9.98e-06	5.45e-05	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—MYC—multiple sclerosis	9.98e-06	5.45e-05	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—TGFB1—multiple sclerosis	9.96e-06	5.44e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—CCL2—multiple sclerosis	9.93e-06	5.43e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—APOE—multiple sclerosis	9.86e-06	5.38e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CCR5—multiple sclerosis	9.86e-06	5.38e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—BCHE—multiple sclerosis	9.84e-06	5.38e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—APOE—multiple sclerosis	9.84e-06	5.37e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—CD80—multiple sclerosis	9.82e-06	5.37e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—APOE—multiple sclerosis	9.8e-06	5.36e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—POMC—multiple sclerosis	9.8e-06	5.35e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—IL2—multiple sclerosis	9.79e-06	5.35e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—APOE—multiple sclerosis	9.77e-06	5.34e-05	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—MAPK1—multiple sclerosis	9.76e-06	5.33e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—POMC—multiple sclerosis	9.75e-06	5.33e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling by GPCR—IL6—multiple sclerosis	9.74e-06	5.32e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling by GPCR—MAPK1—multiple sclerosis	9.72e-06	5.31e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—IL2RA—multiple sclerosis	9.71e-06	5.31e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—APOE—multiple sclerosis	9.68e-06	5.29e-05	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—IL6—multiple sclerosis	9.68e-06	5.29e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—APOE—multiple sclerosis	9.65e-06	5.27e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—IL2—multiple sclerosis	9.64e-06	5.27e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—CCL2—multiple sclerosis	9.59e-06	5.24e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—CCL2—multiple sclerosis	9.54e-06	5.21e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—POMC—multiple sclerosis	9.48e-06	5.18e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling by GPCR—MAPK1—multiple sclerosis	9.38e-06	5.13e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—MAPK1—multiple sclerosis	9.34e-06	5.1e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—POMC—multiple sclerosis	9.33e-06	5.1e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—CCL2—multiple sclerosis	9.28e-06	5.07e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—MMP9—multiple sclerosis	9.26e-06	5.06e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—IL2—multiple sclerosis	9.23e-06	5.04e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—POMC—multiple sclerosis	9.21e-06	5.03e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling by GPCR—IL6—multiple sclerosis	9.19e-06	5.02e-05	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—ALB—multiple sclerosis	9.15e-06	5e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—CCL2—multiple sclerosis	9.13e-06	4.99e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—MAPK1—multiple sclerosis	9.08e-06	4.96e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CD80—multiple sclerosis	9.06e-06	4.95e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—TYK2—multiple sclerosis	9.02e-06	4.93e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—APOE—multiple sclerosis	8.97e-06	4.9e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—MAPK1—multiple sclerosis	8.94e-06	4.88e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—IL2—multiple sclerosis	8.94e-06	4.88e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CD80—multiple sclerosis	8.91e-06	4.87e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CD80—multiple sclerosis	8.89e-06	4.86e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling by GPCR—IL6—multiple sclerosis	8.89e-06	4.86e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CD80—multiple sclerosis	8.86e-06	4.84e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—IL2—multiple sclerosis	8.84e-06	4.83e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CD80—multiple sclerosis	8.84e-06	4.83e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling by GPCR—IL6—multiple sclerosis	8.8e-06	4.81e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CD80—multiple sclerosis	8.75e-06	4.78e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—MMP9—multiple sclerosis	8.74e-06	4.77e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CD80—multiple sclerosis	8.73e-06	4.77e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—TYK2—multiple sclerosis	8.71e-06	4.76e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—TYK2—multiple sclerosis	8.66e-06	4.73e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—POMC—multiple sclerosis	8.61e-06	4.7e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—POMC—multiple sclerosis	8.47e-06	4.63e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—MMP9—multiple sclerosis	8.46e-06	4.62e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—POMC—multiple sclerosis	8.45e-06	4.62e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—TYK2—multiple sclerosis	8.43e-06	4.6e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—POMC—multiple sclerosis	8.42e-06	4.6e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CCL2—multiple sclerosis	8.42e-06	4.6e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—ALB—multiple sclerosis	8.4e-06	4.59e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—POMC—multiple sclerosis	8.4e-06	4.59e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—MMP9—multiple sclerosis	8.37e-06	4.57e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—IL2—multiple sclerosis	8.31e-06	4.54e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—POMC—multiple sclerosis	8.31e-06	4.54e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—TYK2—multiple sclerosis	8.29e-06	4.53e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—POMC—multiple sclerosis	8.29e-06	4.53e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CCL2—multiple sclerosis	8.29e-06	4.53e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling by GPCR—IL6—multiple sclerosis	8.27e-06	4.52e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CCL2—multiple sclerosis	8.27e-06	4.52e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CCL2—multiple sclerosis	8.24e-06	4.5e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—MAPK1—multiple sclerosis	8.24e-06	4.5e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—STAT3—multiple sclerosis	8.24e-06	4.5e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CCL2—multiple sclerosis	8.21e-06	4.49e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CCL2—multiple sclerosis	8.13e-06	4.44e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CCL2—multiple sclerosis	8.11e-06	4.43e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CD80—multiple sclerosis	8.11e-06	4.43e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—MAPK1—multiple sclerosis	8.11e-06	4.43e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—MAPK1—multiple sclerosis	8.09e-06	4.42e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—MAPK1—multiple sclerosis	8.06e-06	4.4e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—MAPK1—multiple sclerosis	8.04e-06	4.39e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—MAPK1—multiple sclerosis	7.96e-06	4.35e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—MAPK1—multiple sclerosis	7.94e-06	4.34e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—MMP9—multiple sclerosis	7.87e-06	4.3e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—STAT3—multiple sclerosis	7.77e-06	4.24e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—POMC—multiple sclerosis	7.7e-06	4.21e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—MYC—multiple sclerosis	7.65e-06	4.18e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—TYK2—multiple sclerosis	7.65e-06	4.18e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—TGFB1—multiple sclerosis	7.64e-06	4.17e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—APOE—multiple sclerosis	7.6e-06	4.15e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—BCHE—multiple sclerosis	7.6e-06	4.15e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CCL2—multiple sclerosis	7.54e-06	4.12e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—TYK2—multiple sclerosis	7.52e-06	4.11e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—STAT3—multiple sclerosis	7.52e-06	4.11e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—TYK2—multiple sclerosis	7.51e-06	4.1e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—IL2—multiple sclerosis	7.51e-06	4.1e-05	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—IL6—multiple sclerosis	7.5e-06	4.1e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—MAPK1—multiple sclerosis	7.49e-06	4.09e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—TYK2—multiple sclerosis	7.48e-06	4.09e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling by GPCR—IL6—multiple sclerosis	7.47e-06	4.08e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—TYK2—multiple sclerosis	7.46e-06	4.07e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—STAT3—multiple sclerosis	7.44e-06	4.06e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—APOE—multiple sclerosis	7.42e-06	4.05e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—TYK2—multiple sclerosis	7.39e-06	4.03e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—MAPK1—multiple sclerosis	7.38e-06	4.03e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—TYK2—multiple sclerosis	7.37e-06	4.02e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—IL2—multiple sclerosis	7.25e-06	3.96e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—MYC—multiple sclerosis	7.22e-06	3.94e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling by GPCR—IL6—multiple sclerosis	7.21e-06	3.94e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—IL2—multiple sclerosis	7.21e-06	3.94e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—TGFB1—multiple sclerosis	7.2e-06	3.93e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—IL6—multiple sclerosis	7.17e-06	3.92e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—MMP9—multiple sclerosis	7.1e-06	3.88e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—MAPK1—multiple sclerosis	7.06e-06	3.86e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—IL2—multiple sclerosis	7.01e-06	3.83e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—STAT3—multiple sclerosis	7e-06	3.82e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—APOE—multiple sclerosis	6.99e-06	3.82e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—MYC—multiple sclerosis	6.99e-06	3.82e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—IL6—multiple sclerosis	6.98e-06	3.81e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—TGFB1—multiple sclerosis	6.97e-06	3.81e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—APOE—multiple sclerosis	6.93e-06	3.78e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—MYC—multiple sclerosis	6.91e-06	3.78e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—IL2—multiple sclerosis	6.9e-06	3.77e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—TGFB1—multiple sclerosis	6.9e-06	3.77e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—IL6—multiple sclerosis	6.87e-06	3.75e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—MMP9—multiple sclerosis	6.86e-06	3.75e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—TYK2—multiple sclerosis	6.84e-06	3.74e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—MAPK1—multiple sclerosis	6.84e-06	3.73e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—MMP9—multiple sclerosis	6.82e-06	3.73e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—MAPK1—multiple sclerosis	6.76e-06	3.7e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—MMP9—multiple sclerosis	6.64e-06	3.62e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—MMP9—multiple sclerosis	6.53e-06	3.57e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—POMC—multiple sclerosis	6.53e-06	3.57e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—MYC—multiple sclerosis	6.5e-06	3.55e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—TGFB1—multiple sclerosis	6.49e-06	3.54e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—POMC—multiple sclerosis	6.37e-06	3.48e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—IL2—multiple sclerosis	6.36e-06	3.48e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—MAPK1—multiple sclerosis	6.36e-06	3.47e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—IL6—multiple sclerosis	6.33e-06	3.46e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—STAT3—multiple sclerosis	6.32e-06	3.45e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—IL2—multiple sclerosis	6.26e-06	3.42e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—IL2—multiple sclerosis	6.25e-06	3.41e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—IL6—multiple sclerosis	6.23e-06	3.4e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—IL2—multiple sclerosis	6.23e-06	3.4e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—IL6—multiple sclerosis	6.22e-06	3.4e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—IL2—multiple sclerosis	6.21e-06	3.39e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—IL6—multiple sclerosis	6.2e-06	3.38e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—IL6—multiple sclerosis	6.18e-06	3.37e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—IL2—multiple sclerosis	6.15e-06	3.36e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—IL2—multiple sclerosis	6.13e-06	3.35e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—IL6—multiple sclerosis	6.12e-06	3.34e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—IL6—multiple sclerosis	6.1e-06	3.33e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—STAT3—multiple sclerosis	6.1e-06	3.33e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—STAT3—multiple sclerosis	6.07e-06	3.31e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—MMP9—multiple sclerosis	6.02e-06	3.29e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—POMC—multiple sclerosis	6e-06	3.28e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—POMC—multiple sclerosis	5.95e-06	3.25e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—ALB—multiple sclerosis	5.95e-06	3.25e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—MMP9—multiple sclerosis	5.92e-06	3.24e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—APOE—multiple sclerosis	5.92e-06	3.23e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—MMP9—multiple sclerosis	5.91e-06	3.23e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—STAT3—multiple sclerosis	5.9e-06	3.22e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—MMP9—multiple sclerosis	5.89e-06	3.22e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—MMP9—multiple sclerosis	5.87e-06	3.21e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—MYC—multiple sclerosis	5.87e-06	3.21e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—TGFB1—multiple sclerosis	5.86e-06	3.2e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—MMP9—multiple sclerosis	5.82e-06	3.18e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—ALB—multiple sclerosis	5.81e-06	3.17e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—STAT3—multiple sclerosis	5.81e-06	3.17e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—MMP9—multiple sclerosis	5.8e-06	3.17e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—IL6—multiple sclerosis	5.75e-06	3.14e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—MAPK1—multiple sclerosis	5.74e-06	3.14e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—IL2—multiple sclerosis	5.7e-06	3.11e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—IL6—multiple sclerosis	5.67e-06	3.1e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—MYC—multiple sclerosis	5.67e-06	3.1e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—TGFB1—multiple sclerosis	5.65e-06	3.09e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—MYC—multiple sclerosis	5.64e-06	3.08e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—TGFB1—multiple sclerosis	5.62e-06	3.07e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—MAPK1—multiple sclerosis	5.54e-06	3.03e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—MAPK1—multiple sclerosis	5.51e-06	3.01e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—MYC—multiple sclerosis	5.48e-06	2.99e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—ALB—multiple sclerosis	5.47e-06	2.99e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—TGFB1—multiple sclerosis	5.47e-06	2.99e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—IL6—multiple sclerosis	5.43e-06	2.96e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—ALB—multiple sclerosis	5.43e-06	2.96e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—MYC—multiple sclerosis	5.4e-06	2.95e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MMP9—multiple sclerosis	5.39e-06	2.94e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—TGFB1—multiple sclerosis	5.38e-06	2.94e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—MAPK1—multiple sclerosis	5.36e-06	2.93e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—STAT3—multiple sclerosis	5.35e-06	2.92e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—MAPK1—multiple sclerosis	5.28e-06	2.88e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—STAT3—multiple sclerosis	5.27e-06	2.88e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—STAT3—multiple sclerosis	5.26e-06	2.87e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—IL6—multiple sclerosis	5.25e-06	2.87e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—STAT3—multiple sclerosis	5.24e-06	2.86e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—STAT3—multiple sclerosis	5.22e-06	2.85e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—IL6—multiple sclerosis	5.2e-06	2.84e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—STAT3—multiple sclerosis	5.17e-06	2.83e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—STAT3—multiple sclerosis	5.16e-06	2.82e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—POMC—multiple sclerosis	5.09e-06	2.78e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—MYC—multiple sclerosis	4.97e-06	2.72e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—TGFB1—multiple sclerosis	4.96e-06	2.71e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—MYC—multiple sclerosis	4.9e-06	2.67e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—IL6—multiple sclerosis	4.89e-06	2.67e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—MYC—multiple sclerosis	4.88e-06	2.67e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—TGFB1—multiple sclerosis	4.88e-06	2.67e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—TGFB1—multiple sclerosis	4.87e-06	2.66e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—MYC—multiple sclerosis	4.87e-06	2.66e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—MAPK1—multiple sclerosis	4.87e-06	2.66e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—TGFB1—multiple sclerosis	4.86e-06	2.65e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—MYC—multiple sclerosis	4.85e-06	2.65e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—TGFB1—multiple sclerosis	4.84e-06	2.64e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—MYC—multiple sclerosis	4.81e-06	2.63e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—TGFB1—multiple sclerosis	4.79e-06	2.62e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—MYC—multiple sclerosis	4.79e-06	2.62e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—STAT3—multiple sclerosis	4.79e-06	2.62e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—MAPK1—multiple sclerosis	4.79e-06	2.62e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—TGFB1—multiple sclerosis	4.78e-06	2.61e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—MAPK1—multiple sclerosis	4.78e-06	2.61e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—MAPK1—multiple sclerosis	4.76e-06	2.6e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—MAPK1—multiple sclerosis	4.75e-06	2.59e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—MAPK1—multiple sclerosis	4.7e-06	2.57e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—MAPK1—multiple sclerosis	4.69e-06	2.56e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—ALB—multiple sclerosis	4.64e-06	2.53e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—APOE—multiple sclerosis	4.57e-06	2.5e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MYC—multiple sclerosis	4.45e-06	2.43e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—TGFB1—multiple sclerosis	4.44e-06	2.43e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—IL6—multiple sclerosis	4.41e-06	2.41e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MAPK1—multiple sclerosis	4.36e-06	2.38e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—IL6—multiple sclerosis	4.26e-06	2.33e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—IL6—multiple sclerosis	4.24e-06	2.31e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—IL6—multiple sclerosis	4.12e-06	2.25e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—IL6—multiple sclerosis	4.06e-06	2.22e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—POMC—multiple sclerosis	3.93e-06	2.14e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—IL6—multiple sclerosis	3.74e-06	2.04e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—IL6—multiple sclerosis	3.68e-06	2.01e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—IL6—multiple sclerosis	3.67e-06	2.01e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—IL6—multiple sclerosis	3.66e-06	2e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—IL6—multiple sclerosis	3.65e-06	1.99e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—IL6—multiple sclerosis	3.61e-06	1.97e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—IL6—multiple sclerosis	3.6e-06	1.97e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—ALB—multiple sclerosis	3.58e-06	1.95e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—IL6—multiple sclerosis	3.35e-06	1.83e-05	CbGpPWpGaD
